
BIO 2009: Stem Cell Companies’ ‘Fate’ Relies on Interdisciplinary Business Models
I attended the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session at BIO on Monday, which featured a panel of specialists: G. Steven Burrill, CEO, Burrill & Company, Aaron Rowe, […]